¿Cómo pueden las empresas de biotecnología aprovechar un estudio de mercado eficaz?

The advent of biotecnología has been something of a miracle in itself. It has completely revolutionized the salud and pharma industry over the last 20-30 years. As the potential of biotech to solve problems in every category from healthcare to agriculture increases, so does the size and strength of the industry. As published by DatafoxEn 2012, los productos biotecnológicos representaron 21% del total del mercado mundial de medicamentos de venta con receta, $714 mil millones, lo que equivale a $150 mil millones de ventas. Y se espera que crezca hasta los $224.000 millones para el $2018.

New products and innovations are an everyday affair when it comes to biotech. One category of products that is taking the industry by storm right now is biomaterials. Biomaterials have the potential to repair tissue and work as substitutes for missing tissue. A good example of a biomaterial is collagen, which is being used in a wide range of applications, from dentistry to drug delivery systems.

If you walk into a pharmacy, you’re likely to find a whole range of collagen products – from those that promise to make your skin look younger and to those that make your bones/cartilage stronger. There are multiple brands manufacturing the same product. As a biotech firm, how then, can you position your product differently? You’d need to have a report of the current industry practices and products – their sources, composition and effectiveness.

Traditionally, companies have bought standard, over-the-counter market research reports to assess the market for their product and to keep themselves updated with scientific developments. However, there is often a time lag between the publication of a report and the latest, ongoing research. Companies also have to scour through various reports to finally find one that is of particular interest to them, and more often than not, the report doesn’t present evidence-based answers that directly relate to the questions at hand.

En estos casos, contratar a un experto independiente que pueda preparar un informe específico para el producto y los requisitos de la empresa puede resultar muy útil. Poder discutir sus requisitos con un científico le da la flexibilidad de explicar sus requisitos y no tener que perder tiempo y energía leyendo informe tras informe.

Another growing category of biotech products is biomarcadores. Typically, a biomarker is anything that gives you an indication of the biological state of an organism – for example, a warm forehead might mean a fever. However, novel biomarkers can now help us diagnose a disease and also predict how the patient will respond to a certain kind of treatment. We know that some specific genes, if inherited, can signify increased chance of having cancer or schizophrenia. Biomarkers help measure the immune response of a patient to specific antibodies, so that the most effective form of treatment can be developed. In case the patient has a mutated gene, for example, it may lower the response of the patient to the drug. Biomarkers are being used in cancer diagnostics, drug discovery and personalized medicine. The market for biomarkers is expected to grow in the next five years, as more and more companies are jumping into the bandwagon.

Encontrar al especialista adecuado para un informe de investigación de mercado personalizado ayuda a las empresas a tomar decisiones bien informadas y calculadas. Es esencial que las empresas biotecnológicas trabajen mano a mano con los investigadores para mantenerse al tanto de las últimas innovaciones y desarrollos de productos. Trabajar con un científico independiente le dota de los conocimientos necesarios para impulsar sus decisiones empresariales, mejorar los productos existentes, posicionar los nuevos y encontrar el público objetivo adecuado. Consultar a un investigador de forma individualizada para obtener un informe personalizado también puede resultar mucho más barato que obtener informes de agencias de venta libre. La entrega personalizada no se limita a la medicina.

The third sector of biotech that is seeing widespread application is what forms the backbone of biotech – good ol’ genética. With a rise in incidence of hereditary diseases, technological advances and public awareness, the global market for genetic testing is predicted to crecer en 500 millones de dólares in the next four years. Research also shows that personalized medicine is future of healthcare. Genetics forms the foundation of predictive diagnostics, oncología, genómica and sequencing, and drives a large part of the industry forward. Genetic engineering also has large applications in the agriculture and energy sectors.

Para una empresa de biotecnología emergente o de tamaño medio puede ser toda una tarea encontrar toda la literatura que necesita para desarrollar un nuevo producto. Y no olvidemos a las empresas más grandes y consolidadas, que también necesitan estar al día de los avances científicos para poder sostener sus productos y mantener los estándares y protocolos de la industria. En lugar de pagar una gran cantidad de dinero por informes precreados, es mucho más eficaz para una empresa poder acceder a servicios personalizados en un solo lugar.

En pocas palabras, he aquí por qué las PYME de biotecnología deberían trabajar con especialistas autónomos de forma individual:

Dado que el sector de la biotecnología es muy prometedor para el futuro, es esencial que las empresas se planteen la innovación a lo grande. Una investigación exhaustiva y minuciosa sienta las bases de cualquier producto novedoso, y nuestro grupo de científicos de todo el mundo están aquí para hacerlo.